EP Patent

EP3426227A1 — Composition and method of use of colchicine oral liquid

Assigned to Rxomeg Therapeutics LLC · Expires 2019-01-16 · 7y expired

What this patent protects

Oral liquid colchicine formulations are described herein. Methods of using the oral liquid colchicine formulations are also provided.

USPTO Abstract

Oral liquid colchicine formulations are described herein. Methods of using the oral liquid colchicine formulations are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP3426227A1
Jurisdiction
EP
Classification
—
Expires
2019-01-16
Drug substance claim
No
Drug product claim
No
Assignee
Rxomeg Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.